6
Total investments
5
Early stage
1
Mid stage
0
Late stage
8y
Years active
Portfolio
6 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor - Series A
Mar 2026
AfterQuery is an applied research lab curating data solutions to accelerate foundation model development.
Seed Investor
Jun 2024
Our Mission
Our mission is to empower patients of all ages to look and feel their best by optimizing their peak physical performance and emotional well-being.
Our Vision
At Excel Health, we envision a world where every individual, regardless of their age, experiences a life filled with vitality and celebration.
Our Philosophy
Our philosophy is simple: every age is a gift. We believe in celebrating every phase of life, ensuring that aging is not just embraced, but celebrated with luxury and top-tier care.
Where are Excel Health wellness centers located?
Our integrated wellness centers, nestled in America’s most sought-after travel destinations, blend the pinnacle of medical expertise with indulgent concierge services. We are dedicated to redefining the narrative of aging, where each passing year becomes a source of joy, marked by the fusion of opulent comfort and cutting-edge care. Our commitment is to enrich every life by not merely extending its duration, but by infusing each year with unforgettable moments of beauty, health, and wellbeing.
Investor
Aug 2022
At Possible, we believe financial health is something everyone deserves. It’s our mission to help communities break the debt cycle and unlock economic mobility for generations to come.
We’re unwavering in our commitment to this mission, and love building products and services that prove changing the industry for the better is, in fact, Possible.
Join us.
Investor
Dec 2020
AltPep develops early disease-modifying treatments and detection tools for amyloid diseases by targeting one of the earliest molecular triggers – toxic soluble oligomers. These oligomers are associated with many diseases, including neurodegenerative diseases and type 2 diabetes. Decades of scientific research by the Daggett Research Group culminated in the discovery of a novel protein structure, alpha-sheet, the foundation of our innovative approach.
Our lead program aims to identify Alzheimer’s Disease long before symptoms occur and then neutralize the toxic soluble oligomers associated with the disease.
Investor
Feb 2020
Carlsmed is a commercial-stage medical technology leader and creator of the personalized spine surgery market with pioneering technology that is transforming spine surgery. The Company has developed the cutting-edge aprevo® Technology Platform that personalizes surgical procedures through a combination of proprietary AI-driven software and patient-specific fusion devices.
Seed Investor
Dec 2018
Amplify Surgical creates surgical solutions that transform the ordinary implants and instruments into clinically-relevant surgical systems that provide successful clinical results.
Working closely with our surgeon partners and distributor network, Amplify Surgical delivers extraordinary surgical solutions that amplify clinical results bringing patients back to their active lives quickly.
Experience · 8 entries
All (8)
Investments (6)
2026
Investor - Series A
Mar 2026
AfterQuery is an applied research lab curating data solutions to accelerate foundation model development.
2024
Seed Investor
Jun 2024
Our Mission
Our mission is to empower patients of all ages to look and feel their best by optimizing their peak physical performance and emotional well-being.
Our Vision
At Excel Health, we envision a world where every individual, regardless of their age, experiences a life filled with vitality and celebration.
Our Philosophy
Our philosophy is simple: every age is a gift. We believe in celebrating every phase of life, ensuring that aging is not just embraced, but celebrated with luxury and top-tier care.
Where are Excel Health wellness centers located?
Our integrated wellness centers, nestled in America’s most sought-after travel destinations, blend the pinnacle of medical expertise with indulgent concierge services. We are dedicated to redefining the narrative of aging, where each passing year becomes a source of joy, marked by the fusion of opulent comfort and cutting-edge care. Our commitment is to enrich every life by not merely extending its duration, but by infusing each year with unforgettable moments of beauty, health, and wellbeing.
2022
Investor
Aug 2022
At Possible, we believe financial health is something everyone deserves. It’s our mission to help communities break the debt cycle and unlock economic mobility for generations to come.
We’re unwavering in our commitment to this mission, and love building products and services that prove changing the industry for the better is, in fact, Possible.
Join us.
Limited Partner
Feb 2022
Unlock Venture Partners is a venture capital firm focused on early-stage technology investments in Seattle and Los Angeles. At Unlock, we invest in entrepreneurs that have deep conviction and unique insight on how best to utilize data and AI to disrupt large industries.
Investments include Possible, Crowd Cow, Make.TV (acquired by LTN Global), Downticket, Stackin, Chatititve (acquired by Mailchimp), Outer, Downstream (acquired by Jungle Scout), Concreit, Fight Camp, Dolly (acquired by Updater), Plunk, UNest, Mango Sciences, Fantasmo, Sensate, iLife, Mandala Space Ventures, Seasalt.AI, Hola Cash, Continuum Space Systems, DRESSX, Irreverent Labs, Gen.G and Vitrina.AI.
Past investments by the principals include Cheezburger Network, SoFi, JW Player, Sparq, Remitly (Tkr: RELY), Redfin (Tkr: RDFN), NetCracker Technologies, Rover (Tkr: ROVR), Jetlore, BuddyTV, Buuteeq, Klout and Minted.
Startups whod like to talk to Unlock - please submit info at https://unlockvp.com/contact-us/
2020
Investor
Dec 2020
AltPep develops early disease-modifying treatments and detection tools for amyloid diseases by targeting one of the earliest molecular triggers – toxic soluble oligomers. These oligomers are associated with many diseases, including neurodegenerative diseases and type 2 diabetes. Decades of scientific research by the Daggett Research Group culminated in the discovery of a novel protein structure, alpha-sheet, the foundation of our innovative approach.
Our lead program aims to identify Alzheimer’s Disease long before symptoms occur and then neutralize the toxic soluble oligomers associated with the disease.
Show all 8 entries ↓
Investment activity
2018–2026 · 6 investments
Recent (last 2 years)Earlier
